Back
Adaptive Biotechnologies Stock Price Chart
Buy
52
ADPT
Adaptive Biotechnologies
Last Price:
3.60
Seasonality Move:
11.74%
7 Day Trial
ALL ACCESS PASS
$
7
- The current trend is moderately bullish and ADPT is experiencing selling pressure, which indicates risk of future bearish movement.
Adaptive Biotechnologies Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.66 | Sell |
| 20-day SMA: | 3.13 | Buy |
| 50-day SMA: | 3.06 | Buy |
| 200-day SMA: | 4.4 | Sell |
| 8-day EMA: | 3.6 | Buy |
| 20-day EMA: | 3.31 | Buy |
| 50-day EMA: | 3.25 | Buy |
| 200-day EMA: | 4.5 | Sell |
Adaptive Biotechnologies Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.24 | Buy |
| Relative Strength Index (14 RSI): | 60.11 | Buy |
| Chaikin Money Flow: | -910243 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.52 - 3.52) | Buy |
| Bollinger Bands (100): | (2.91 - 4.29) | Buy |
Adaptive Biotechnologies Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Adaptive Biotechnologies Stock
Is Adaptive Biotechnologies Stock a Buy?
- Adaptive Biotechnologies share price is 3.61 while ADPT 8-day simple moving average is 3.66, which is a Sell signal.
- The stock price of ADPT is 3.61 while Adaptive Biotechnologies 20-day SMA is 3.13, which makes it a Buy.
- Adaptive Biotechnologies 50-day simple moving average is 3.06 while ADPT share price is 3.61, making it a Buy technically.
- ADPT stock price is 3.61 and Adaptive Biotechnologies 200-day simple moving average is 4.40, creating a Sell signal.
ADPT Technical Analysis vs Fundamental Analysis
Buy
52
Adaptive Biotechnologies (ADPT)
is a Buy
Is Adaptive Biotechnologies a Buy or a Sell?
-
Adaptive Biotechnologies stock is rated a Buy
The current Adaptive Biotechnologies [ADPT] share price is $3.61. The Score for ADPT is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
Adaptive Biotechnologies Stock Info
Market Cap:
532M
Price in USD:
3.61
Share Volume:
1.57M
Adaptive Biotechnologies 52-Week Range
52-Week High:
9.08
52-Week Low:
2.28
Buy
52
Adaptive Biotechnologies (ADPT)
is a Buy
Adaptive Biotechnologies Share Price Forecast
-
What is the Adaptive Biotechnologies stock price today?
The Adaptive Biotechnologies stock price is 3.61 USD today. -
Will ADPT stock go up or go down?
Adaptive Biotechnologies> share price is forecast to RISE/FALL based on technical indicators -
Is Adaptive Biotechnologies overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Adaptive Biotechnologies is not overvalued.
Is Adaptive Biotechnologies Stock a Buy?
- Adaptive Biotechnologies share price is 3.61 while ADPT 8-day exponential moving average is 3.60, which is a Buy signal.
- The stock price of ADPT is 3.61 while Adaptive Biotechnologies 20-day EMA is 3.31, which makes it a Buy.
- Adaptive Biotechnologies 50-day exponential moving average is 3.25 while ADPT share price is 3.61, making it a Buy technically.
- ADPT stock price is 3.61 and Adaptive Biotechnologies 200-day simple moving average is 4.50, creating a Sell signal.
Fundamental Analysis of Adaptive Biotechnologies
Is Adaptive Biotechnologies a good investment?
- Analysts estimate an earnings increase this quarter of $0.02 per share, an increase next quarter of $0.03 per share, an increase this year of $0.11 per share, and an increase next year of $0.26 per share.
Technical Analysis of Adaptive Biotechnologies
Should I short Adaptive Biotechnologies stock?
- ADPT Moving Average Covergence Divergence (MACD) indicator is 0.24, suggesting Adaptive Biotechnologies is a Buy
- Adaptive Biotechnologies Relative Strength Index (RSI) is 60.11, which suggest Adaptive Biotechnologies is overbought
- The Bollinger Bands (25) for Adaptive Biotechnologies is (2.52 - 3.52), which suggest Adaptive Biotechnologies is a Buy
- The Bollinger Bands (100) for Adaptive Biotechnologies is (2.91 - 4.29), which suggest Adaptive Biotechnologies is a Buy
* Adaptive Biotechnologies stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.